华森制药(002907.SZ)甲磺酸雷沙吉兰片完成境内生产药品备案

Core Viewpoint - Huason Pharmaceutical (002907.SZ) has announced that its product, Apsaglar (Apsaglar tablets), has completed the domestic production drug filing and the application for the aging-friendly drug label, which has been publicly disclosed on the National Medical Products Administration (NMPA) website [1] Group 1 - The product Apsaglar has received approval for domestic production drug filing [1] - The application for aging-friendly drug labeling has been successfully submitted [1] - The filing information has been officially published on the NMPA website [1]